for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Orthopediatrics Corp

KIDS.OQ

Latest Trade

38.00USD

Change

-0.72(-1.86%)

Volume

56,287

Today's Range

37.54

 - 

39.65

52 Week Range

26.03

 - 

47.82

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
38.72
Open
38.83
Volume
56,287
3M AVG Volume
1.88
Today's High
39.65
Today's Low
37.54
52 Week High
47.82
52 Week Low
26.03
Shares Out (MIL)
14.94
Market Cap (MIL)
567.70
Forward P/E
-48.24
Dividend (Yield %)
--

Next Event

OrthoPediatrics Corp at Cantor Fitzgerald Global Healthcare Conference

Latest Developments

More

Orthopediatrics Corp Receives FDA 510(K) Clearance For First Pediatric-Specific Foot System

Orthopediatrics Q2 Loss Per Share $0.18 Including Items

Orthopediatrics Corp. Receives FDA 510(K) Clearance For Next Generation Cannulated Screw System

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Orthopediatrics Corp

OrthoPediatrics Corp. is an orthopedic company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems. Its products include PediNail Intramedullary Nail System, PediLoc Plating Systems, ACL Reconstruction System, Locking Cannulated Blade (LCB) plate system, Locking Proximal Femur (LPF) plate system, PediFlex Flexible Nailing System, PediFrag, PediLoc Extension Osteotomy Plate (PLEO), PediLoc Femur Locking Plate System, PediLoc Tibia Locking Plate System, PediPlates system and Spica Table.

Industry

Medical Equipment & Supplies

Contact Info

2850 Frontier Dr

+1.574.2686379

http://www.orthopediatrics.com/

Executive Leadership

Terry D. Schlotterback

Independent Chairman of the Board

Mark C. Throdahl

President, Chief Executive Officer, Director

Fred L. Hite

Chief Financial Officer, Director

David R. Bailey

Executive Vice President

Gregory A. Odle

Executive Vice President

Key Stats

1.71 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.0K

2018

0.1K

2019(E)

0.1K
EPS (USD)

2017

-5.590

2018

-0.960

2019(E)

-0.788
Price To Earnings (TTM)
--
Price To Sales (TTM)
8.98
Price To Book (MRQ)
6.45
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
58.17
LT Debt To Equity (MRQ)
23.97
Return on Investment (TTM)
-11.11
Return on Equity (TTM)
-8.56

Latest News

BRIEF-Orthopediatrics Corp Q1 Loss Per Share $0.41

* Q1 EARNINGS PER SHARE VIEW $-0.30 -- THOMSON REUTERS I/B/E/S

BRIEF-OrthoPediatrics Q4 Loss Per Share $4.35

* REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Orthopediatrics Announces Preliminary Revenue For Q4

* ANNOUNCES PRELIMINARY REVENUE FOR FOURTH QUARTER AND FULL YEAR 2017

BRIEF-Orthopediatrics Corp Appoints Samuel Riccitelli To Its Board

* ORTHOPEDIATRICS CORP. APPOINTS SAMUEL D. RICCITELLI TO ITS BOARD OF DIRECTORS

BRIEF-Orthopediatrics Reports third quarter 2017 financial results

* Orthopediatrics Corp. Reports third quarter 2017 financial results

BRIEF-Orthopediatrics shares open at $18 in debut, up 38.5 pct from IPO price

* Orthopediatrics Corp shares open at $18 in debut on the NASDAQ vs IPO price of $13 per share Further company coverage:

BRIEF-ORTHOPEDIATRICS CORP. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

* ORTHOPEDIATRICS CORP. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

BRIEF-OrthoPediatrics Corp sees IPO of 4 mln shares of its common stock priced between $12-$14/shr

* OrthoPediatrics Corp sees IPO of 4 million shares of its common stock priced between $12.00 and $14.00 per share - SEC filing Source text: (http://bit.ly/2xV65Xb) Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up